Thanks to this huge development, Novo Nordisk's stock could get another boost

It may not be too late to invest in this promising healthcare stock, even though it may look expensive. Novovo Nordisk's stock could get another boost, thanks to this huge development. Novo Nordisk is a promising healthcare company, but it may be too expensive for investors.

Bernie Sanders wants to meet next week with Novo Nordisk CEO about lowering the price of Ozempic. The drug is fueling controversy over the costs of GLP-1 drugs for diabetes and obesity. Senator Sanders Wants to Meet Novo CEO Next Week on Ozempin Price.

Bernie Sanders calls on Novo Nordisk to lower cost of Ozempic and Wegovy. Sanders’ calls for lower drug prices has become a hallmark of his politics. Sanders' calls for drug prices have become a signature of his political movement. He has called for the drug companies to lower their prices.